23andMe and TrialSpark Announce Joint Clinical Trial Offering and Request For Proposals

Thursday, September 26, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

- 23andMe and TrialSpark are collaborating on a reimagined clinical trial offering that is patient-centric and uniquely data-driven

1.

Impact report: Analysis and insights into critical drug development issues. Tufts Center for the Study of Drug Development. 2013;15(1)

2.

Borno HT, Zhang L, Siegel A, et al. At what cost to clinical trial enrollment? A retrospective study of patient travel burden in cancer clinical trials. Oncologist. 2018 Oct;23(10):1242-1249.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store